First-of-its-Kind

MTEC uses a first-of-its-kind funding mechanism that enables both the government and private sponsors to support groundbreaking medical research

MTEC has been able to expand its funding base using a blended funding construct in which private sector and philanthropic funds augment government sponsor contributions.

To leverage this innovative funding structure, MTEC partnered with The Allergan Foundation, a U.S.-based, private charitable foundation that supports programs working to improve patient diagnosis, treatment, care, and quality of life. Through MTEC, The Allergan Foundation recently awarded funding to Stanford University (PI: Dr. Jeffrey Goldberg) to continue a vision restoration research effort originally funded by the Army via MTEC.

Soldiers in the battlefield are exposed to significant trauma through blasts, penetrating wounds and burns. Among the most prevalent injuries are those related to the eye, which account for 12-15% of all battlefield wounds (>15% of these result in the removal of the eye). In the U.S. alone, 2.9 million people are visually impaired and 1.3 million are blind, of which over 50,000 are veterans. These significant numbers demand solutions because of the impact that vision loss has on an individual’s quality of life. Unfortunately, the optic nerve (which relays visual information back to the brain) cannot regenerate itself and there are no current treatments that elicit visual recovery after traumatic or ischemic injury to the optic nerve, or in degenerative disorders such as glaucoma. This funding will be used to support the development of a critically-needed prototype that enhances optic nerve regeneration.

Funding provided by private sponsors or investors allows MTEC to facilitate the development and application of new medical technologies that help heal our warfighters and veterans. MTEC would like to give a special thanks to The Allergan Foundation for its generous gift!